Funds withdrawn in DTP litigation
The solicitors suing GlaxoSmithKline for alleged side-
effects of DTP vaccine have had their public funding withdrawn because the evidence is unlikely to result in a successful outcome.
The Manchester-based firm, Alexander Harris, had laun-ched a class action involving 120 people into the alleged relationship between the pertussis component of the vaccine and severe brain injury shortly after immunisation. The cases go back to the 1960s.
Writs had been issued to a 'considerable number' of GPs who failed to log the batch number of the DTP vaccine used to immunise these children but, ultimately, any claim would have been made against the manufacturer.
A spokeswoman for Alex-ander Harris said the Legal Services Commission concluded the evidence available was unlikely to result in a successful action.
The firm is considering appealing the decision.